1. Introduction {#sec1}
===============

According to DSM-5 depression is a common mental disorder that presents with depressed mood, loss of interest (pleasure), decreased energy, feeling of guilt, or low self-worth, disturbed sleep or appetite, and poor concentration \[[@B1]\]. HIV/AIDS is a chronic infectious disease and first leading cause of mortality and morbidity worldwide from an infectious disease. An estimated 5 million young people aged 15-24 years are living with HIV, vast majority in sub-Saharan Africa \[[@B2]\]. Depressive disorders were the third leading cause of global burden of disease in 2004 and will be the first by 2030. Globally depression is number one cause of illness and disability among youth \[[@B3]--[@B7]\].Youth and young adults account for a large percentage of all HIV/AIDS cases in Ethiopia \[[@B8]\]. AIDS death has risen only among adolescents and young age group since 2001 \[[@B9], [@B10]\]. There is an evidence of significant comorbidity in people living with HIV/AIDS (PLWHA) including depression \[[@B4], [@B5]\].

Different studies have shown the global magnitude of depression among HIV-positive youth to vary across the world. About 44% in America \[[@B11]\] and in Africa, studies report prevalence to ranges between 12 and 60% \[[@B12]\]. Another studies in Malawi, Malaysia, and Kenya revealed that the prevalence of depression among HIV-positive youth was 18.9%, 18.3%, and 48%, respectively \[[@B4], [@B5], [@B13]\].

Mental health and HIV/AIDS are closely interlinked. Living with HIV/AIDS can increase the risk of mental illness such as depression. While poor mental health can inspire behaviors which place individuals at risk for HIV/AIDS \[[@B14]\]. Depression negatively affects HIV disease prognosis. It decreases CD4 T lymphocytes activity, increases viral load, and affects quality of life and medication adherence, which contributes a greater risk of mortality \[[@B15]\].

There are a number of moderating factors for depression in PLWHA. The moderating factors were age, gender, primary care giver type, maternal death, change in care giver type, death in the family \[[@B14], [@B16], [@B17]\], failing in the school term, medication adherence, HIV related stigma, and poor social support which were the major moderating factors for depression among HIV-positive youth \[[@B4], [@B18], [@B19]\].

Depression in youth has also been correlated with high risk behaviors including earlier sexual debut, low condom use, substance abuse, more frequent sexual partners, and unplanned pregnancy \[[@B4], [@B5]\].

Youth and young adults account for a large percentage of all HIV/AIDS cases in Ethiopia. Living with HIV/AIDS can increase the risk of mental illness such as depression. Even though neuropsychiatric comorbidities (including depression) are highly prevalent among HIV-positive youth worldwide, there are no studies which show prevalence of depression among HIV-positive youth in Ethiopia. So determining prevalence of depressive symptoms and associated factors among HIV-positive youth is important for early intervention and further decreases the burden of depression and contributes to have a plane for improving patients\' quality of life.

2. Methods and Materials {#sec2}
========================

2.1. Study Settings and Populations {#sec2.1}
-----------------------------------

An institution based cross sectional study was conducted in nine hospitals (Black Lion, Ras Desta, St. Peter and Yekatit 12, Gandhi memorial, Minlik II, St. Paulos, Alert, and Zeweditu Memorial Hospital) in Addis Ababa, Ethiopia, between May and June 2016. The study subjects were selected from these public hospitals using systematic random sampling technique for interview.

2.2. Measurement {#sec2.2}
----------------

Beck Depression Inventory-II (BDI-II) was used to assess the presence and severity of depressive symptoms. The tool consists of 21 items and patients with a score greater than or equal to 21 \[[@B4]\] were taken as having depressive symptoms. The sociodemographic factors were age, sex educational status, and marital status.

The four-item Morsiky Medication Adherence Rating Scale (MMARS) questionnaire was used to measure drug nonadherence. The cut point of 3 and above was used to define nonadherence \[[@B20]\]. Social support was assessed by adolescent social support rating scale. The scale has three broad categories "low social support" (1-2.9), "moderate social support" (3-5), and "strong social support" (5.1-7) \[[@B21]\]. Stigma was measured by a 12-item HIV stigma scale \[[@B22]\]. The scale consists of four-point Likert scale (strongly disagree, disagree, agree, and strongly agree) questions concerning disclosure status, negative self-image, and public attitudes. Data regarding stages of HIV, base line CD4 count, types of ART, and history of opportunistic infection were obtained from patient\'s medical chart.

2.3. Data Collection {#sec2.3}
--------------------

Data were collected by four trained data collectors (general nurses) using the Amharic version of the questionnaire for a month. The questionnaire was designed in English and was translated to Amharic and back to English, that is, forward and backward translation. The training was on introduction to depression and HIV comorbidity, research methods, interviewing skills, sampling and recruitment, and ethical aspects of research.

2.4. Data Processing and Analysis {#sec2.4}
---------------------------------

All collected data were checked for completeness and consistency and entered in to EPI INFO version 7 and then exported to SPSS for windows version 20 for analysis.

Descriptive and bivariate logistic regression analyses were computed to see frequency distribution and to test whether there was an association between the independent and dependent variables, respectively. Factors associated with depressive symptoms were selected during bivariate analysis with a value of p≤0.2 for further analysis in multivariable regression analysis. Variables with P-value less than 0.05 at 95% confidence interval were considered as statistically significant.

2.5. Ethical Consideration {#sec2.5}
--------------------------

Ethical clearance was obtained from University of Gondar institutional review board. Permission was obtained from Addis Ababa City Administration Health Bureau Ethical Committee. Written consent was taken from study participants and assent from legally approved foster parents after explaining purpose of the study. Confidentiality was maintained by omitting their personal identification.

3. Results {#sec3}
==========

A total of 507 participants out of 537 enrolled were included in the study making the response rate 94.4%. The mean age of participants was 18.6 years (±SD =3.024) and 272 (69.6%) were females. Concerning educational status, about 232 (45.8%) had attended primary education. From a total of participants 243 (47.9%) were living with father/mother ([Table 1](#tab1){ref-type="table"}).

Out of the total respondents the majority 280 (75%) were on WHO stage I and II disease and 409 (80.7%) were taking first line ART treatment. About 283 (55.6%) had poor adherence on medications and 261 (51.5%) experienced stigma because of their HIV status ([Table 2](#tab2){ref-type="table"}, see Appendix).

3.1. Prevalence of Depressive Symptoms {#sec3.1}
--------------------------------------

In our finding the prevalence of depressive symptoms among the study participants was 35.5 % with 95% CI (31.3%, 39.6%).

3.2. Factors Associated with Depressive Symptoms among HIV-Positive Youth {#sec3.2}
-------------------------------------------------------------------------

Bivariate analysis indicated that sociodemographic variables (age, sex, educational status, primary care giver type, and living status), clinical variables (stage of HIV and history of opportunistic infections), and psychosocial factors (stigma, adherence, social support, and ever use of substance) were significantly associated with depressive symptoms. In the multivariate model age, history of opportunistic infection, experience of stigma, poor medication adherence, and low and moderate social support were statistically significant with depressive symptoms ([Table 3](#tab3){ref-type="table"}, see Appendix).

4. Discussion {#sec4}
=============

Prevalence of depressive symptoms among HIV-positive youth was 35.5% with 95% CI (31.3%, 39.6%) based on the Beck inventory scale. The rate is lower than reported rates in Zimbabwe 63% \[[@B23]\], Kenya 48% \[[@B24]\], and USA 52 % \[[@B25]\]. The possible reason for this variation might be due to the difference in study design, sample size, and data collection tools. It might also be related to substance, stigmatization, and low social support. Substance use may increase risk of HIV infection and AIDS and interfere with their treatment, and conversely some mental disorders occur as a direct result of HIV infection. Youth with depression may have low in treatment service for HIV/AIDS. On the other hand, our rates are higher than the study done in Malawi, 18.9% \[[@B4]\] Kenya 17.8% \[[@B13]\], and Malaysia 18.5 % \[[@B26]\]. The possible reason for this discrepancy might also be due to the study design and data collection tools. It might also be due to very poor medication adherence and presence of opportunistic infection in our study.

Our study identified an association between age and depressive symptoms among youth with HIV. Specifically, age range from 20 to 24 years was significantly associated with depressive symptoms. The odds of developing depressive symptoms among participants with age range of 20-24 years were 2.2 (AOR= 2.20, 95% CI: 1.33, 3.62) times higher compared with age range of 15-19 years. As age increases the level of understanding and conceptualizing their HIV status also increases as well as entry to adult hood which may be fraught with developmental challenges. It might be difficult for youth coping with HIV since birth, including ongoing treatment and hospitalization which leads to low self-image. The aforementioned study from Malawi \[[@B4]\] and USA \[[@B25]\] also identified the relationship between increased age and depression.

Respondents who had poor adherence on medication were 1.73 times more likely to develop depressive symptoms than those respondents who had good adherence on medication (AOR =1.73, 95%CI: 1.13, 2.64). This might be due to poor medication adherence which has been implicated in the emergence of drug resistance strains of HIV, which results in decrease in virology suppression. The finding is supported by study in Zimbabwe \[[@B11]\] and Kano, North Western Nigeria \[[@B27]\].

With respect to social support respondents who had moderate social support and low social support were 1.75 and 2.74 times more likely to develop depressive symptoms than those who had strong social support with AOR= 1.75, 95% CI: 1.03, 2.98 and AOR =2.74 95%CI: 1.42, 5.27, respectively. Young people with no close family to disclose their problem are unable to get care and may have increased depressive symptoms \[[@B25]\]. This might also be due to decreased social support within the context of HIV; AIDS is related to increased depression because of various factors such as educational disability, food insecurity, isolation, and debilitation. Low social support could result in poor adherence to medication and as a result poor adherence leads to immune suppression which finally leads to depression \[[@B13], [@B28]\].

HIV related stigma increases the individual vulnerability 2.06 times in risk of developing depressive symptoms with (AOR=2.06, 95% CI: 1.35, 3.14). Our finding is consistent with the study done in different developed and developing countries \[[@B29], [@B30]\]. It might be related to the fact that young people with HIV status develop increase in sense of isolation, poor self-worth, and rekindle hopelessness which might lead to psychological distress.

With regard to opportunistic infections, respondents who had history of opportunistic infections were 1.94 times in risk of developing depressive symptoms (AOR=1.94 95% CI:1.15, 3.27). Immunosuppression and dissatisfaction with one\'s physical appearance, all possibly the results of HIV infection, could result in depression. The aforementioned study done in Malawi also supports the current study \[[@B4]\].

There were several limitations. The design of the study was cross sectional; therefore we were unable to conclude any causal direction of the association found and have no information regarding timing (onset) of depressive symptoms. Many of the variables were self-reported and therefore the respondents may be influenced by social desirability bias.

5. Conclusion {#sec5}
=============

HIV-positive young people were at high risk of developing depression. Importantly this study demonstrates a high prevalence of depressive symptoms among HIV-positive youth attending ART follow-up at public hospitals. Age, history of opportunistic infection, HIV related stigma, poor medication adherence, and low and moderate social support were found to be independent predictor of depressive symptoms. Integration of mental health evaluation and treatment into the HIV care provided for youth can be beneficial. More studies to delineate factors associated with depressed youth with HIV may add value to the body of knowledge and overall improvement of care. The limitation of this study was social desirability bias.
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See Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}.
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###### 

Sociodemographic characteristics of HIV positive youth on ART follow-up at selected public hospitals in Addis Ababa, Ethiopia, 2016 (n=507).

  Characteristics                  Number   Percent (%)
  -------------------------------- -------- -------------
  Age                                        
   15-19                           353      69.6
   20-24                           154      30.4
  Sex                                        
   Female                          272      53.6
   Male                            235      46.4
  Educational status                         
   Primary                         232      45.8
   Secondary                       212      41.8
   Diploma and above               63       12.4
  Primary care giver                         
   Both mother and father          214      42.2
   Other siblings                  293      57.8
  Living status of mother/father             
   Mother/father died              243      47.9
   Both died                       107      21.1
   Both alive                      157      31.0

Others = grandmother/father, aunt/uncle, and brother/sister.

###### 

Distribution of clinical, stigma, and psychosocial factors among HIV positive youth attending ART follow-up at public hospitals in Addis Ababa, Ethiopia, 2016(n=507).

  Characteristics                 Frequency   Percent (%)
  ------------------------------- ----------- -------------
  Stage of HIV                                 
   Stages 1 and 2                 380         75
   Stages 3 and 4                 127         25
  ART type                                     
   First line                     409         80.7
   Second line                    98          19.3
  Opportunistic infection                      
   Yes                            162         32
   No                             345         68
  CD4 count                                    
   0-300                          206         40.6
   \>350                          301         59.4
  Stigma                                       
   Yes                            261         51.5
   No                             246         48.5
  Adherence                                    
   Poor                           282         55.6
   Good                           225         44.4
  Social support                               
   Low                            92          18.1
   Moderate                       293         57.8
   Strong                         122         24.1
  Taunt for physical appearance                
   Yes                            47          9.3
   No                             460         90.7
  Taunt for taking ART                         
   Yes                            15          3.0
   No                             492         97.0
  Substance use                                
   Yes                            152         30
   No                             355         70

###### 

Factors associated with depression among HIV positive youth attending ART follow-up at public hospitals in Addis Ababa, Ethiopia, 2016 (n= 507).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Characteristics**               **Depression**   **COR**     **AOR**                                                   
  --------------------------------- ---------------- ----------- ---------------------- ---------------------------------- ----------------------------------------
  **Age**                           15-19            99(28.0)    254(72.0)              1.00                               1.00

  20-24                             81(52.6)         73(47.4)    **2.84(1.92, 4.21)**   **2.20(1.33, 3.62)** **∗** **∗**   

  Sex                               Female           105(38.6)   167(61.4)              1.34(0.92, 1.93)                   1.21(0.79, 1.84)

  Male                              75(31.9)         160(68.1)   1.00                   1.00                               

  Educational status                Primary          73(31.5)    159(68.5)              0.47(0.26, 0.83)                   0.70(0.35, 1.37)

  Secondary                         76(35.8)         136(64.2)   0.57(0.32, 1.01)       0.99(0.50, 1.96)                   

  Diploma and above                 31(49.2)         32(50.8)    1.00                   1.00                               

  Primary care giver                Other sibling    120(41.0)   173(59.0)              1.78(1.21, 2.59)                   0.88(0.53, 1.47)

  Mother/father                     60(28.0)         154(72.0)   1.00                   1.00                               

  living status of mother /father   Both dead        29(27.1)    78(72.9)               0.62(0.41, 0.93)                   0.73(0.36,1.47)

  Mother/father died                81(33.3)         162(66.7)   0.46(0.27, 0.78)       1.04(0.62, 1.75)                   

  Both alive                        70(44.6)         87(55.4)    1.00                   1.00\                              

  Stages of HIV                     Stage 3&4        54(42.5)    73(57.5)               0.67(0.44, 1.01)                   1.00(0.55, 1.82)

  Stage 1&2                         126(33.2)        254(66.8)   1.00                   1.00                               

  **Opportunistic infection**       Yes              74(45.7)    88(54.3)               **1.89(1.29, 2.78)**               **1.94(1.15, 3.27)** **∗** **∗**

  No                                106(30.7)        239(69.3)   1.00                   1.00\                              

  **Stigma**                        Yes              116(41.2)   132(52.8)              **2.74(1.88,4.00)**                **2.06(1.35, 3.14)** **∗** **∗** **∗**

  No                                64(24.5)         197(75.5)   1.00                   1.00                               

  **Adherence**                     Poor             121(42.9)   161(57.1)              **2.11(1.44, 3.09)**               **1.73(1.13, 2.64)** **∗** **∗**

  Good                              59(26.2)         166(73.8)   1.00                   1.00                               

  **Social support**                Low              44(47.8)    48(52.2)               **3.22(1.78, 5.82)**               **2.74(1.42, 5.27)** **∗** **∗**

  Moderate                          109(37.2)        184(62.8)   **2.08(1.27, 3.39)**   **1.75(1.03, 2.98)** **∗**         

  Strong                            27(22.1)         95(77.9)    1.00                   1.00                               

  CD4 count                         0-350            80(38.8)    201(66.8)              1.27(0.88, 1.84)                   0.93(0.57, 1.50)

  \>350                             100(33.2)        126(61.2)                                                             

  Substances\                       Yes              80(52.6)    72(47.4)               2.83(1.91, 4.19)                   1.85(0.68, 4.99)

  No                                100(28.2)        255(71.8)   1.00                   1.00                               
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------

. *∗∗∗*  ***indicates p-value\<0.001,  *∗∗*indicates p-value\<0.01, and  *∗*indicates p-value \<0.05.***
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